Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1993-8-30
|
| pubmed:abstractText |
We reviewed a series of 194 lung opacities presumed to be bronchogenic carcinomas occurring either simultaneously with (n = 46) or metachronously to (n = 148) a head and neck cancer. The purpose of the study was to evaluate the operative mortality and morbidity and to assess with a survival analysis whether the lung lesions actually were primary carcinomas or metastases of the head and neck cancer. Operation was contraindicated in 77 patients: 36 for metastatic spread, 5 for small-cell carcinoma, and 35 for respiratory insufficiency. The remaining 118 underwent operation: lobectomy for 82, pneumonectomy for 30, wedge resection for 1, and exploratory thoracotomy for 5. The operative mortality was 5%, and the nonfatal morbidity was 22%. The survival at 5 years for patients who underwent operation for bronchogenic cancer was 19.7% (27.2% for stage I, 19% for stage II, 4.5% for stage IIIA, and 0% for stage IIIB). The survival of these patients was not significantly different with respect to the synchronous or metachronous occurrence or the histologic classification (squamous or non-squamous). We conclude that, despite the poor survival, several of these lung lesions associated with a head and neck cancer were most likely a primary bronchogenic cancer. Surgical management is justified because of the observed postoperative mortality.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0022-5223
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
106
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
218-27
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8393506-Adult,
pubmed-meshheading:8393506-Aged,
pubmed-meshheading:8393506-Aged, 80 and over,
pubmed-meshheading:8393506-Bone Neoplasms,
pubmed-meshheading:8393506-Carcinoma, Bronchogenic,
pubmed-meshheading:8393506-Carcinoma, Small Cell,
pubmed-meshheading:8393506-Carcinoma, Squamous Cell,
pubmed-meshheading:8393506-Combined Modality Therapy,
pubmed-meshheading:8393506-Female,
pubmed-meshheading:8393506-Follow-Up Studies,
pubmed-meshheading:8393506-Head and Neck Neoplasms,
pubmed-meshheading:8393506-Humans,
pubmed-meshheading:8393506-Lung Neoplasms,
pubmed-meshheading:8393506-Male,
pubmed-meshheading:8393506-Middle Aged,
pubmed-meshheading:8393506-Neoplasm Staging,
pubmed-meshheading:8393506-Neoplasms, Multiple Primary,
pubmed-meshheading:8393506-Postoperative Complications,
pubmed-meshheading:8393506-Survival Rate
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients.
|
| pubmed:affiliation |
Service de Chirurgie Thoracique, Hospices Civils, Strasbourg, France.
|
| pubmed:publicationType |
Journal Article
|